Work

Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes

Year: 2022

Type: review

Source: Current Atherosclerosis Reports

DOI: 10.1007/s11883-022-01066-y

Authors: Kunal K. Jha, Rishav Adhikari, Erfan Tasdighi, Ngozi Osuji, Tanuja Rajan, Michael J. Blaha

Institutions: Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4309889982

FWCI: 0.355

Cites: 58

Cited by: 11

Related to: 10